Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study

BACKGROUND: The CHAARTED and LATITUDE trials demonstrated a prolonged overall survival (OS) for metastatic hormone-naïve prostate cancer (mHNPC) patients who receive up-front docetaxel or abiraterone acetate. These studies used their own risk criteria: CHAARTED trial defines high- and low-volume dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Kawahara, Takashi, Yoneyama, Shuko, Ohno, Yoshio, Iizuka, Junpei, Hashimoto, Yasunobu, Tsumura, Hideyasu, Tabata, Ken-ichi, Nakagami, Yoshihiro, Tanabe, Kazunari, Iwamura, Masatsugu, Uemura, Hiroji, Miyoshi, Yasuhide
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352129/
https://ncbi.nlm.nih.gov/pubmed/32714984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7804932
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars